{"entity":{"type":"insider","cik":"0001864116","url":"/insider/0001864116","json_url":"/insider/0001864116.json","name":"Bellinger Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":7,"first":"2021-06-21","last":"2022-12-02","span_basis":"filed_date"},"name_variants":[{"name":"Bellinger Andrew","source":"filing","n_filings":7,"first_seen":"2021-06-21","last_seen":"2022-12-02"}],"transactions":[{"id":6548984,"accession":"0001209191-22-059438","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059438","line_url":"/filing/0001209191-22-059438#line-1","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (CSO & CMO)","role_mark":"O","role_mark_label":"Officer (CSO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":865.0,"shares_display":"865","price_per_share":22.95,"price_display":"22.95","price_state":"stated","total_value":19851.75,"total_display":"19,851.75","total_whole":"19,852","shares_owned_after":6629.0,"shares_owned_after_display":"6,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":6854117,"accession":"0001209191-22-055063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-055063","line_url":"/filing/0001209191-22-055063#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (CSO & CMO)","role_mark":"O","role_mark_label":"Officer (CSO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":39.9,"price_display":"39.90","price_state":"stated","total_value":399000.0,"total_display":"399,000.00","total_whole":"399,000","shares_owned_after":6629.0,"shares_owned_after_display":"6,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-11-01","scope":"insider"},{"id":6613506,"accession":"0001209191-22-051374","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-22-051374","line_url":"/filing/0001209191-22-051374","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (CSO & CMO)","role_mark":"O","role_mark_label":"Officer (CSO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":35.33986624333333,"price_display":"35.34","price_state":"stated","total_value":2120391.9746,"total_display":"2,120,391.97","total_whole":"2,120,392","shares_owned_after":9831.0,"shares_owned_after_display":"9,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-27","scope":"insider","n_lines":4},{"id":6631166,"accession":"0001209191-22-043018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043018","line_url":"/filing/0001209191-22-043018#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (CSO & CMO)","role_mark":"O","role_mark_label":"Officer (CSO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":34.9,"price_display":"34.90","price_state":"stated","total_value":698000.0,"total_display":"698,000.00","total_whole":"698,000","shares_owned_after":6629.0,"shares_owned_after_display":"6,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-20","filed_date":"2022-07-22","scope":"insider"},{"id":6786171,"accession":"0001209191-22-042264","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042264","line_url":"/filing/0001209191-22-042264#line-2","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (CSO & CMO)","role_mark":"O","role_mark_label":"Officer (CSO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.9,"price_display":"24.90","price_state":"stated","total_value":249000.0,"total_display":"249,000.00","total_whole":"249,000","shares_owned_after":6629.0,"shares_owned_after_display":"6,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-13","filed_date":"2022-07-15","scope":"insider"},{"id":4869460,"accession":"0000899243-21-049814","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-049814","line_url":"/filing/0000899243-21-049814","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":38.697934233333335,"price_display":"38.70","price_state":"stated","total_value":580469.0135,"total_display":"580,469.01","total_whole":"580,469","shares_owned_after":9871.0,"shares_owned_after_display":"9,871","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-27","scope":"insider","n_lines":3},{"id":4087797,"accession":"0000899243-21-025071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025071","line_url":"/filing/0000899243-21-025071#line-1","is_derivative":false,"issuer_cik":"0001840574","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001840574","owner_cik":"0001864116","owner_name":"Bellinger Andrew","owner_display_name":"Bellinger Andrew","owner_url":"/insider/0001864116","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":95000.0,"total_display":"95,000.00","total_whole":"95,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Officer (CSO & CMO)","n_filings":7,"first_seen":"2021-06-21","last_seen":"2022-12-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001864116","retrieved_at":"2026-08-25T18:01:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}